Institutional investors purchased a net $3.9 million shares of STML during the quarter ended March 2015, and now own 65.33% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FARALLON CAPITAL MANAGEMENT LLC Bought 577.6 Thousand shares of Stemline Therapeutics Inc
GREAT POINT PARTNERS LLC Bought 475.2 Thousand shares of Stemline Therapeutics Inc